| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |